Ex vivo modulation of tau phosphorylation by hyperpolarized light: implications for Alzheimer’s disease therapy
Emiliana Piscitiello, Barbara Truglia, Sara Castria, Alessandra Occhinegro, Elisa De Angelis, Luca Alberti, Ludovico Taddei, Timna Hitrec, Roberto Amici, Jack A. Tuszynski, Marco Luppi

Alzheimer’s disease (AD) is characterized by amyloid-β accumulation and tau hyperphosphorylation, leading to neurodegeneration and cognitive decline. Photobiomodulation (PBM) has shown promise in mitigating AD pathology, yet its effects on tau remain poorly understood. We investigated the impact of high-polarized light (HPL; Bioptron Quantum Hyperlight, 350–3400 nm) on tau phosphorylation using an ex vivo rat brain slice model of synthetic torpor (ST), a reversible hypometabolic state inducing controlled tau hyperphosphorylation. Slices were incubated at physiological (37 °C) or hypometabolic (25 °C) temperatures and exposed to HPL for 10 or 20 minutes. Western blot analyses of Tau-1 (non-phosphorylated tau), p-GSK3β (Ser9), and p-T205 revealed that HPL increased Tau-1 levels in warm slices, indicating a shift toward reduced tau hyperphosphorylation. p-GSK3β modulation was variable, reflecting inter-animal differences and temperature-dependent kinase/phosphatase dynamics. Cold slices exhibited smaller, more heterogeneous responses, consistent with suppressed metabolic activity and attenuated PBM signaling. Site-specific p-T205 changes suggest transient kinase activation and redox signaling, compatible with an overall trend toward normalized tau phosphorylation. These results highlight how HPL can modulate tau phosphorylation ex vivo, with the most consistent effects under normothermic conditions. Despite limitations, our findings provide preliminary evidence supporting HPL/PBM as a potential therapeutic strategy for tauopathies. Future in vivo studies are warranted to elucidate mechanisms, optimize dosing, and explore glymphatic-mediated clearance in PBM-treated brains.
Keywords: photobiomodulation, hyperpolarized light, Alzheimer, hypothermia, synthetic torpor, tau hyperphosphorylation
How to Cite this paper:
Emiliana Piscitiello, Barbara Truglia, Sara Castria, Alessandra Occhinegro, Elisa De Angelis, Luca Alberti, Ludovico Taddei, Timna Hitrec, Roberto Amici, Jack A. Tuszynski, Marco Luppi (2025) Ex vivo modulation of tau phosphorylation by hyperpolarized light: implications for Alzheimer’s disease therapy, Journal of Multiscale Neuroscience 4(3), 244-256. DOI: https://doi.org/10.56280/1714956796
Author Affiliation:
Emiliana Piscitiello
1University of Bologna, Department of Biomedical and Neuromotor Sciences, Bologna, Italy, 40127.
Barbara Truglia
University of Alberta, Faculty of Engineering, Department of Biomedical Engineering, Edmonton, Canada, T6G1H9.
Sara Castria
Politecnico di Torino, Faculty of Engineering, Department of Mechanical and Aerospace Engineering (DIMEAS), Turin, Italy, 10129.
Alessandra Occhinegro
University of Bologna, Department of Biomedical and Neuromotor Sciences, Bologna, Italy, 40127.
Elisa De Angelis
University of Bologna, Department of Biomedical and Neuromotor Sciences, Bologna, Italy, 40127.
Luca Alberti
University of Bologna, Department of Biomedical and Neuromotor Sciences, Bologna, Italy, 40127.
Ludovico Taddei
University of Bologna, Department of Biomedical and Neuromotor Sciences, Bologna, Italy, 40127.
Timna Hitrec
University of Bologna, Department of Biomedical and Neuromotor Sciences, Bologna, Italy, 40127.
Roberto Amici
University of Bologna, Department of Biomedical and Neuromotor Sciences, Bologna, Italy, 40127.
Jack A. Tuszynski
University of Alberta, Faculty of Science, Department of Physics, Edmonton, Canada, T6G2E1.
Politecnico di Torino, Faculty of Engineering, Department of Mechanical and Aerospace Engineering (DIMEAS), Turin, Italy, 10129.
Marco Luppi
University of Bologna, Department of Biomedical and Neuromotor Sciences, Bologna, Italy, 40127.
Received: 31 August 2025
Accepted: 29 September 2025
Online Published: 30 September 2025
Conflict of Interest
The author declares no conflict of interest
Copyright: © 2025 The Author(s). Published by Neural Press.
This is an open access article distributed under the terms and conditions of the CC BY 4.0 license.
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, Neural Press™ or the editors, and the reviewers. Any product that may be evaluated in this article, or claim that made by its manufacturer, is not guaranteed or endorsed by the publisher
References
Avila, J. (2006) Tau phosphorylation and aggregation in Alzheimer’s disease pathology. FEBS Letters 580, 2922–2927.
Beurel, E., Grieco, S.F. & Jope, R.S. (2015) Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases. Pharmacology & Therapeutics 148, 114–131.
BIOPTRON (n.d.) Hyperlight. Available at: https://www.bioptron.com/how-it-works/bioptron-hyperlight-therapy/
Butterfield, D.A. & Boyd-Kimball, D. (2018) Oxidative stress, amyloid-β peptide, and altered key molecular pathways in the pathogenesis and progression of Alzheimer’s disease. Journal of Alzheimer’s Disease 62, 1345–1367.
Calabrò, M., Rinaldi, C., Santoro, G., & Crisafulli, C. (2021) The biological pathways of Alzheimer disease: a review. AIMS Neuroscience 8, 86–132.
Cerri, M., Mastrotto, M., Tupone, D., Martelli, D., Luppi, M. et al. (2013) The inhibition of neurons in the central nervous pathways for thermoregulatory cold defense induces a suspended animation state in the rat. Journal of Neuroscience 33, 2984–2993.
Lin, H., Li, D., Zhu, J., Liu, S., Yu, T. et al. (2024) Transcranial photobiomodulation for brain diseases: review of animal and human studies including mechanisms and emerging trends. Neurophotonics 11, 010601.
Luppi, M., Hitrec, T., Di Cristoforo, A., Squarcio, F., Stanzani, A. et al. (2019) Phosphorylation and dephosphorylation of tau protein during synthetic torpor. Frontiers in Neuroanatomy 13, 57

.png)